- Home
- VIR vs VINP Comparison
VIR vs VINP Comparison
Compare VIR & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- VINP
- Stock Information
- Founded
- VIR 2016
- VINP 2009
- Country
- VIR United States
- VINP Brazil
- Employees
- VIR N/A
- VINP N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- VIR Health Care
- VINP Finance
- Exchange
- VIR Nasdaq
- VINP Nasdaq
- Market Cap
- VIR 706.4M
- VINP 671.7M
- IPO Year
- VIR 2019
- VINP 2021
- Fundamental
- Price
- VIR $5.63
- VINP $10.61
- Analyst Decision
- VIR Strong Buy
- VINP Strong Buy
- Analyst Count
- VIR 11
- VINP 2
- Target Price
- VIR $25.73
- VINP $13.50
- AVG Volume (30 Days)
- VIR 1.1M
- VINP 46.3K
- Earning Date
- VIR 10-30-2025
- VINP 11-06-2025
- Dividend Yield
- VIR N/A
- VINP 6.13%
- EPS Growth
- VIR N/A
- VINP N/A
- EPS
- VIR N/A
- VINP 0.50
- Revenue
- VIR $19,000,000.00
- VINP $153,475,995.00
- Revenue This Year
- VIR N/A
- VINP $68.12
- Revenue Next Year
- VIR $15.25
- VINP $14.85
- P/E Ratio
- VIR N/A
- VINP $21.12
- Revenue Growth
- VIR N/A
- VINP 76.11
- 52 Week Low
- VIR $4.16
- VINP $8.66
- 52 Week High
- VIR $14.45
- VINP $10.99
- Technical
- Relative Strength Index (RSI)
- VIR 59.22
- VINP 59.19
- Support Level
- VIR $5.36
- VINP $10.50
- Resistance Level
- VIR $6.00
- VINP $10.83
- Average True Range (ATR)
- VIR 0.28
- VINP 0.25
- MACD
- VIR 0.03
- VINP -0.01
- Stochastic Oscillator
- VIR 65.62
- VINP 67.09
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.